Advertisement

Effects of Long-Term Neuroleptic Treatment on Serum Levels of Prolactin, TSH, LH, and Norepinephrine and on α-Adrenergic and Dopaminergic Receptor Sensitivity

Relations to Tardive Dyskinesia
  • Dieter Naber
  • Franz Müller

Abstract

Neuroendocrine effects of catecholamine receptor-blocking neuroleptic drugs have been investigated in numerous studies (Ackenheil, 1981; Brambilla et al., 1979a; Burt et al., 1977; Carlsson, 1978, Collu et al., 1977; Ettigi et al., 1976; Meltzer et al., 1978; Pandey et al., 1977; Sachar, 1978); in particular, the increase of serum prolactin (PRL) after acute neuroleptic treatment is well documented (Gruen et al., 1978; Langer et al., 1977; Rubin and Hays, 1980, Wode-Helgodt, et al., 1977). There are, however, only a few studies dealing with the neuroendocrine effects of chronic neuroleptic treatment. As both differ distinctly, inferring long-term effects from short-term effects is inappropriate (Ler-ner et al., 1977). Moreover, there are striking differences in the reactivity of the tuberoinfundibular, nigrostrial, mesolimbic, and mesocortical dopaminergic systems to long-term treatment with neuroleptics (Bowers and Rozitis, 1974; Julou et al., 1977).

Keywords

Schizophrenic Patient Tardive Dyskinesia Drug Withdrawal Neuroleptic Drug Neuroleptic Treatment 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Ackenheil, M., 1981, Biochemical effects of apomorphine: Contribution to schizophrenia research, in: Apomorphine and Other Dopaminomimetics, Vol. 2, Clinical Research (G. L. Gessa and G. U. Corsini, eds.), pp. 215–225, Raven Press, New York.Google Scholar
  2. Ackenheil, M., Albus, M., Müller, F., Müller, T., Welter, D., Zander, K., and Engel, R., 1979, Catecholamine response to short-time stress in schizophrenic and depressive patients, in: Catecholamines: Basic and Clinical Frontiers, Vol. 2 (E. Usdin, A. Coppen, and J. Barchas, eds.), pp. 1937–1941, Pergamon Press, Elmsford, N.Y.Google Scholar
  3. Andén, N. E., Butcher, S. G., Carrodi, H., Fuxe, K., and Ungerstedt, U., 1970, Receptor activity and turnover of dopamine and noradrenaline after neuroleptics, Eur. J. Pharmacol. 11:303.PubMedCrossRefGoogle Scholar
  4. Aratö, M., Erdös, A., and Polgŕ, M., 1979, Endocrinological changes in patients with sexual dysfunction under long-term neuroleptic treatment, Pharmakopsychiatr. Neuro-psychopharmakol. 12:426.Google Scholar
  5. Bartholini, G., Keller, H. H., and Pletscher, A., 1973, Effect of neuroleptics on endogenous norepinephrine in rat brain, Neuropharmacology 12:751.PubMedCrossRefGoogle Scholar
  6. Beaumont, P. J. V., Corker, C. S., Friesen, H. G., Kolakowska, T., Mandelbrote, B. M., Marshall, J., Murray, M. A. F., and Wiles, D. H., 1974, The effects of phenothiazines on endocrine function. II. Effects in men and post-menopausal women, Br. J. Psychiatry 124:420.CrossRefGoogle Scholar
  7. Bowers, M. B., Jr., and Rozitis, A., 1974, Regional differences in homovanillic acid concentrations after acute and chronic administration of antipsychotic drugs, J. Pharm. Pharmacol. 26:743.PubMedCrossRefGoogle Scholar
  8. Brambilla, F., Guerrini, A., Gaustalla, A., Rovere, C., and Riggi, F., 1975, Neuroendocrine effects of haloperidol therapy in chronic schizophrenics, Psychopharmacologia 44:17.PubMedCrossRefGoogle Scholar
  9. Brambilla, F., Bellodi, L., Negri, F., Smeraldi, E., and Malagoli, G., 1979a, Dopamine receptor sensitivity in the hypothalamus of chronic schizophrenics after haloperidol therapy: Growth hormone and prolactin response to stimuli, Psychoneuroendocrinology 4:329.PubMedCrossRefGoogle Scholar
  10. Brambilla, F., Riggi, F., Guerrini, A., Malagoli, G., and Guastalla, A., 1979b, The effect of prolonged sulpiride therapy on pituitary-gonadal function in male psychotic patients, Clin. Ther. 2:91.Google Scholar
  11. Bürki, H. R., Ruch, W., Asper, H., Baggiolini, M., and Stille, G., 1974, Effect of single and repeated administration of clozapine on the metabolism of dopamine and noradrenaline in the brain of the rat, Eur. J. Pharmacol. 27:180.PubMedCrossRefGoogle Scholar
  12. Burt, D. R., Creese, I., and Snyder, S. H., 1977, Antischizophrenic drugs: Chronic treatment elevates dopamine receptor binding in brain, Science 196:326.PubMedCrossRefGoogle Scholar
  13. Carlsson, A., 1978, Antipsychotic drugs, neurotransmitters, and schizophrenia, Am. J. Psychiatry 135:164.Google Scholar
  14. Christensen, A. V., and Moller-Nielsen, I., 1980. On the supersensitivity of DA-receptors after single and repeated administration of neuroleptics, in: Tardive Dyskinesia (W. E. Fann, R. C. Smith, J. M. Davis, and E. F. Domino, eds.), pp. 35–50, MTP Press, New York.CrossRefGoogle Scholar
  15. Collu, R., Jequier, J. C., Leboeuf, J., and Ducharme, J. R., 1977, Endocrine effects of pimozide, a specific dopaminergic blocker, J. Clin. Endocrinol. Metab. 44:981.CrossRefGoogle Scholar
  16. Czernik, A., and Kleesiek, K., 1979, Effects of depot neuroleptics on pituitary hormones, Nervenarzt 50:527.PubMedGoogle Scholar
  17. DeRivera, J. L., Lal, S., Ettigi, P., Hontela, S., Muller, H. F., and Friesen, H. G., 1976, Effects of acute and chronic neuroleptic therapy on serum prolactin levels in men and women of different age groups, Clin. Endocrinol. 5:273.CrossRefGoogle Scholar
  18. de Wied, D., and de Jong, W., 1974, Drug effects and hypothalamic-anterior pituitary function, Annu. Rev. Pharmacol. 14:389.CrossRefGoogle Scholar
  19. Ettigi, P., Nair, N. P. V., Lal, S., Cervantes, P., and Guyda, H., 1976, Effect of apomorphine on growth hormone and prolactin secretion in schizophrenic patients, with or without oral dyskinesia, withdrawn from chronic neuroleptic therapy, J. Neurol. Neurosurg. Psychiatry 39:870.PubMedCrossRefGoogle Scholar
  20. Gerlach, J., 1979, Tardive dyskinesia, Dan. Med. Bull. 26:209.PubMedGoogle Scholar
  21. Gruen, H. P., Sachar, E. J., Langer, G., Altman, N., Leifer, M., Frantz, A., and Halpern, F. S., 1978, Prolactin responses to neuroleptics in normals and schizophrenic subjects, Arch. Gen. Psychiatry 35:108.PubMedCrossRefGoogle Scholar
  22. Johnstone, E. C., Crow, T. J., and Mashiter, K., 1977, Anterior pituitary hormone secretion in chronic schizophrenia—An approach to neurohumoral mechanisms, Psychol. Med. 7:223.PubMedCrossRefGoogle Scholar
  23. Julou, L., Scatton, B., and Glowinski, J., 1977, Acute and chronic treatment with neuroleptics: Similarities and differences in their action in nigrostriatal, mesolimbic and mesocortical dopaminergic neurons, in: Advances in Biochemical Psychopharmacology Vol. 16 (E. Costa and G. L. Gessa, eds.), pp. 617–624, Raven Press, New York.Google Scholar
  24. Keller, H. H., Bartholini, G., and Pletscher, A., 1973, Increase of 3-methoxy-4-hydroxypheny-lethylene glycol in rat brain by neuroleptic drugs, Eur. J. Pharmacol. 23:183.PubMedCrossRefGoogle Scholar
  25. Kirkegaard, C., Bjorum, N., Cohn, D., Faber, J., Lauridsen, U. B., and Nekup, J., 1977, Studies on the influence of biogenic amines and psychoactive drugs on the prognostic value of the TRH stimulation test in endogenous depression, Psychoneuroendocrinology 2:131.PubMedCrossRefGoogle Scholar
  26. Klawans, H. L., Goetz, C. G., and Perlik, S., 1980, Tardive dyskinesia: Review and update, Am. J. Psychiatry 137:900.PubMedGoogle Scholar
  27. Kolakowska, T., Wiles, D. H., Gelder, M. G. and McNeilly, A. S., 1976, Clinical significance of plasma chlorpromazine levels, Psychopharmacology 49:101.PubMedGoogle Scholar
  28. Lake, C. R., Ziegler, M. G., and Kopin, I. J., 1976, Use of plasma norepinephrine for evaluation of sympathetic neuronal function in man, Life Sci. 18:1315.PubMedCrossRefGoogle Scholar
  29. Lal, S., De la Vega, C. E., Sourkes, T. L., and Friesen, H. G., 1973, Effect of apomorphine on growth hormone, prolactin, luteinizing hormone and follicle-stimulating hormone levels in human serum, J. Clin. Endocrinol. Metab. 37:719.PubMedCrossRefGoogle Scholar
  30. Lal, S., Tolis, G., Martin, J. B., Brown, G. M., and Guyda, H., 1975, Effect of Clonidine on growth hormone, prolactin, luteinizing hormone, follicle stimulating hormone, and thyroid-stimulating hormone in the serum of normal men, J. Clin. Endocrinol. Metab. 41:827.PubMedCrossRefGoogle Scholar
  31. Lamberg, B. A., Linnoila, M., Fogelholm, R., Olkinuora, M., Kotilainen, P., and Saarinen, P., 1977, The effect of psychotropic drugs on the TSH-response to thyroliberin (TRH), Neuroendocrinology 24:90.PubMedCrossRefGoogle Scholar
  32. Langer, G., Sachar, E. J., Halpern, F. S., Gruen, P. H., and Solomon, M., 1977, The prolactin response to neuroleptic drugs. A test of dopaminergic blockade: Neuroendocrine studies in normal men, J. Clin. Endocrinol. Metab. 45:996.PubMedCrossRefGoogle Scholar
  33. Laughren, T. P., Brown, W. A., and Williams, B. W., 1979, Serum prolactin and clinical state during neuroleptic treatment and withdrawal, Am. J. Psychiatry 136:108.PubMedGoogle Scholar
  34. Lerner, P., Nosé, P., Gordon, E. K., and Lovenberg, W., 1977, Haloperidol: Effect of long-term treatment on rat striatal dopamine synthesis and turnover, Science 197:181.PubMedCrossRefGoogle Scholar
  35. Martin-Du-Pan, R., and Baumann, D., 1979, Neuroendocrine effects of chronic neuroleptic therapy in male psychiatric patients, Psychoneuroendocrinology 3:245.CrossRefGoogle Scholar
  36. Matussek, N., Ackenheil, M., Hippius, H., Müller, F., Schroöder, T., Shultes, H., and Wasilewski, B., 1980, Effect of Clonidine on growth hormone release in psychiatric patients and controls, Psychiatry Res. 2:25.PubMedCrossRefGoogle Scholar
  37. Meltzer, H. Y., and Fang, V. S., 1976, The effect of neuroleptics on serum prolactin in schizophrenic patients, Arch. Gen. Psychiatry 33:279.PubMedCrossRefGoogle Scholar
  38. Meltzer, H. Y., Goode, D. J., and Fang, V. S., 1978, The effect of psychotropic drugs on endocrine function. I. Neuroleptics, precursors and agonists, in: Psychopharmacology: A Generation of Progress (M. A. Lipton, A. DiMascio, and K. F. Killam, eds.), pp. 509–529, Raven Press, New York.Google Scholar
  39. Müller, F., Bartl, S., Fischer, B., Wörner, J., and Ackenheil, M., 1980, Hormonal studies after long-term treatment with neuroleptics, Abstracts of the 12th CINP Congress, Göteborg, Sweden, p. 255.Google Scholar
  40. Muller, P., and Seeman, P., 1978, Dopaminergic supersensitivity after neuroleptics: Time course and specificity, Psychopharmacology 60:1.PubMedCrossRefGoogle Scholar
  41. Murray, M. A., Bancroft, J. H., Anderson, D. C., Tennent, T. G., and Carr, P. J., 1975, Endocrine changes in male sexual deviants after treatment with anti-androgens, oestrogens or tranquilizers, J. Endocrinol. 67:179.PubMedCrossRefGoogle Scholar
  42. Naber, D., Fischer, B., and Ackenheil, M., 1979, Effect of long-term neuroleptic treatment on dopamine tuberoinfundibular system: Development of tolerance? Commun. Psychopharmacol. 3:59.PubMedGoogle Scholar
  43. Naber, D., Ackenheil, M., Laakmann, G., Fischer, B., and von Werder, K., 1980a, Basal and stimulated levels of prolactin, TSH and LH in serum of chronic schizophrenic patients, long-term treated with neuroleptics, Pharmakopsychiatr. Neuro-Psychopharmakol. 13:325.Google Scholar
  44. Naber, D., Finkbeiner, C., Fischer, B., Zander, K. J., and Ackenheil, M., 1980b, Effect of long-term neuroleptic treatment on prolactin and norepinephrine levels in serum of chronic schizophrenics: Relations to psychopathology and extrapyramidal symptoms, Neuropsychobiology 6:181.PubMedCrossRefGoogle Scholar
  45. Naber, D., Steinböck, H., and Greil, W., 1980c, Effects of short- and long-term neuroleptic treatment on thyroid function, Prog. Neuropsychopharmacol. 4:199.PubMedCrossRefGoogle Scholar
  46. Pandey, G. N., Garver, D. L., Tamminga, C., Ericksen, S., Ali, S. L, and Davis, J. M., 1977, Postsynaptic supersensitivity in schizophrenia, Am. J. Psychiatry 134:518.PubMedGoogle Scholar
  47. Rotrosen, J., Angrist, B., Gershon, S., Paquin, J., Branchey, L., Oleshansky, M., Halpern, F., and Sachar, E. J., 1979, Neuroendocrine effects of apomorphine: Characterization of response patterns and application to schizophrenia research, Br. J. Psychiatry 135:444.PubMedCrossRefGoogle Scholar
  48. Rubin, R. T., and Hays, S. E., 1980, The prolactin secretory response to neuroleptic drugs: Mechanisms, applications and limitations, Psychoneuroendocrinology 5:121.PubMedCrossRefGoogle Scholar
  49. Rubin, R. T., Poland, R. E., O’Connor, D., Gouin, P. R., and Tower, B. B., 1976, Selective neuroendocrine effects of low-dose haloperidol in normal adult men, Psychopharmacologia 47:135.PubMedCrossRefGoogle Scholar
  50. Sachar, E. J., 1978, Neuroendocrine response to psychotropic drugs, in: Psychopharmacology: A Generation of Progress (M. A. Lipton, A. DiMascio, and K. F. Killam, eds.), pp. 499–507, Raven Press, New York.Google Scholar
  51. Sarafoff, M., Davis, L., and Rüther, E., 1979, Clozapine induced increase of human plasma norepinephrine, J. Neural Transm. 46:175.PubMedCrossRefGoogle Scholar
  52. Sekso, M., Solter, M., Banovac, K., Vizner, B., and Petek, M., 1977, The effect of dopaminergic drugs on pituitary hormone release in normal subjects, Acta Med. Iugosl. 31:321.PubMedGoogle Scholar
  53. Shader, R. I., and DiMascio, A., 1970, Psychotropic Drug Side Effects: Clinical and Theoretical Perspectives, Williams & Wilkins, Baltimore.Google Scholar
  54. Wiles, D. H., Kolakowska, T., McNeilly, A. S., Mandelbrote, B. M., and Gelder, M. G., 1976, Clinical significance of plasma chlorpromazine levels. I. Plasma levels of the drug, some of its metabolites and prolactin during acute treatment, Psychol. Med. 6:407.PubMedCrossRefGoogle Scholar
  55. Wilson, R. G., Hamilton, J. R., Boyd, W. D., Forrest, A. P. M., Cole, E.N., Boyns, A. R., and Griffiths, K., 1975, The effect of long term phenothiazine therapy on plasma prolactin, Br. J. Psychiatry 127:71.PubMedCrossRefGoogle Scholar
  56. Wode-Helgodt, B., Eneroth, P., Fryö, B., Gullberg, B., and Sedvall, G., 1977, Effect of chlorpromazine treatment on prolactin levels in cerebrospinal fluid and plasma of psychotic patients, Acta Psychiatr. Scand. 56:280.PubMedCrossRefGoogle Scholar
  57. Zander, K. J., Fischer, B., Zimmer, R., and Ackenheil, M., 1981, Long-term neuroleptic treatment of chronic schizophrenic patients: Clinical and biochemical effects of withdrawal, Psychopharmacology 73:43.PubMedCrossRefGoogle Scholar

Copyright information

© Plenum Publishing Corporation 1984

Authors and Affiliations

  • Dieter Naber
    • 1
  • Franz Müller
    • 1
  1. 1.Psychiatric Hospital of the University of MunichMunichGermany

Personalised recommendations